📊 Markets Jolt as China Cuts Rates — Small-Caps React

Good Morning Investors,

Small-caps are back in the spotlight after a wave of market-moving headlines. China’s latest rate cut is shaking up global sentiment, while renewed talk around Fed oversight and rising U.S. pharma imports point to shifting dynamics.

Still, select names are standing out—biotech firms with strong trial data, gold miners reporting high-grade hits, and clean tech players with earnings momentum. Here's what’s rising, what’s dropping, and where smart capital is paying attention.

Matthias Schneider
Editor at Analytica Investor

↑ ↓ 1-day change
Market data: Yesterday’s market close

The small-cap Russell 2000 Index experienced a slight decline (-1.1%) while the S&P/TSX Venture Composite Index saw an uptick (+1.4%) despite overall market volatility. Secondary indices linked to commodities and mining also demonstrated gains, signaling potential growth areas within small-cap sectors.

Notably, China announced key rate cuts which will undoubtedly impact global market dynamics, particularly for small-cap companies with any exposure to China related industries. Bipartisan efforts to alter the selection of the Fed watchdog could also bring major shifts in the regulatory landscape, potentially boosting small-cap performance opportunities.

Developments surrounding ongoing U.S.-China trade talks indicate a continuation of uncertainties in the global market. Yet, some experts, such as Ed Yardeni as reported by CNBC Television, express that the economy is resilient enough to handle this uncertainty. In addition, the surge of pharma imports to the U.S as reported by Reuters, indicates a possible sector of strength and growth opportunity within the small-cap arena.

As per Seeking Alpha's insight, small-cap investors should remain vigilant and flexible under the ongoing trade tensions and current market uncertainties. Overall, while the market may hold a level of unpredictability, careful navigation can help investors tap into potential growth within small-cap stocks.

A Word From Our Partner

Looking for unbiased, fact-based news? Join 1440 today.

Join over 4 million Americans who start their day with 1440 – your daily digest for unbiased, fact-centric news. From politics to sports, we cover it all by analyzing over 100 sources. Our concise, 5-minute read lands in your inbox each morning at no cost. Experience news without the noise; let 1440 help you make up your own mind. Sign up now and invite your friends and family to be part of the informed.

Subscribe to 1440 today.

📈 Biggest Gainers 

- NWTN Inc. ($NWTN NASDAQ) - 34%:

Market Cap: 149,021,848

Specializes in green mobility technology focused on AI, autonomous driving and IoT connectivity with a special emphasis on consumer-oriented smart passenger vehicles.

- Diversified Healthcare Trust ($DHC NASDAQ) - 31%: 

Market Cap: 689,934,960

As a REIT, it owns medical, life science properties, senior living communities, wellness centers throughout the US, managed by The RMR Group Inc.

The 31% increase in the stock's price is a direct result of the announcement of Diversified Healthcare Trust's strong first quarter 2025 results. (1)

- Caravelle International Group ($HTCO NASDAQ) - 25%:

Market Cap: 204,388,101

This ocean technology firm offers international shipping services, carbon-neutral wood desiccation solutions, and vessel services from its base in Singapore.

- Galiano Gold Inc. ($GAU AMEX) - 23%:

Market Cap: 424,312,350

Specializes in exploring, developing, and producing gold, primarily from its Asanko Gold Mine in Ghana, West Africa, headquartered in Vancouver.

The discovery of a new high-grade zone at Abore and the positive results of the infill drilling program as reported in recent press releases directly induced a 23% spike in the stock’s recent prices. (1)

- Tiziana Life Sciences Ltd ($TLSA NASDAQ) - 23%:

Market Cap: 165,988,500

This biotechnology company focuses on developing molecules to treat oncology and immunology diseases, including COVID-19, based in London.

The recent 23% surge in stock value is largely a result of the announcement of comprehensive positive results from the study of Nasal Foralumab in patients with Multiple Sclerosis. (1)

- Cyclacel Pharmaceuticals, Inc. ($CYCC NASDAQ) - 18%:

Market Cap: 134,945,508

It develops cancer treatments in clinical-stage trials including CDK inhibitors, polo-like kinase inhibitors, and novel nucleoside analogues.

The recent 18% surge in the stock’s value was largely propelled by the announcement of a new share exchange agreement making Fitters SDN. BHD. the majority stockholder. (1)

📉 Biggest Losers

- Vivid Seats Inc. ($SEAT NASDAQ) - -38%: 

Market Cap: 227,508,813

Operates as an online secondary marketplace for tickets in the US and Canada, offering tools for inventory and pricing management.

The significant 38% decrease in stock value is a direct result of the disappointing first quarter results announced in recent press releases. (1)

- BRC Inc. ($BRCC NYSE) - -26%:

Market Cap: 138,353,072

Through its subsidiaries, this Utah-based firm roasts and sells coffee, produces media content, and supports military and first responder communities.

The stock's recent 26% drop is due to the negative financial results reported for the first quarter of 2025, as per the recent PR releases. (1)

- Aldeyra Therapeutics, Inc. ($ALDX NASDAQ) - -22%: 

Market Cap: 125,780,760

This biotechnology firm develops and commercializes medicines for immune-mediated ocular and systemic diseases, including clinical trials for COVID-19.

The recent plummet of 22% in stock prices is conceptually linked to an array of public relation releases centered on various legal investigations into potential securities violations, and the negative response from the FDA towards the company's proposed medicine, Reproxalap. (1 2, 3)

- Larimar Therapeutics, Inc. ($LRMR NASDAQ) - -22%: 

Market Cap: 134,458,590

This clinical-stage biotech firm focuses on developing treatments for rare diseases using its unique cell penetrating peptide technology platform.

The revelation of the first quarter 2025 financial results instigated a 22% drop in the stock value. (1)

- Allogene Therapeutics, Inc. ($ALLO NASDAQ) - -21%: 

Market Cap: 279,942,400

This is a clinical stage immuno-oncology enterprise that develops and commercializes genetically engineered allogeneic T cell therapies for treating various types of cancer.

The pronouncement of the upcoming report on first quarter 2025 financial results and business update have directly precipitated a 21% decrease in the stock's value. (1)

- Taysha Gene Therapies, Inc. ($TSHA NASDAQ) - -19%: 

Market Cap: 410,110,000

This gene therapy company focuses on developing treatments for monogenic diseases of the central nervous system using adeno-associated virus-based therapies.

The recent 19% decrease in stock value was primarily driven by the announcement of an inducement grant under Nasdaq Listing Rule 5635(c)(4). (1)

🚀 Biggest Movers

- Plug Power Inc. ($PLUG NASDAQ) - 100,902,783 shares traded with an average volume of 71,353,208 (-1%):

Market Cap: 805,848,498

Specializes in clean hydrogen, zero-emissions fuel cell solutions and related infrastructure for logistics, on-road electric vehicles, stationary power, and other applications worldwide.

- BigBear.ai Holdings, Inc. ($BBAI NYSE) - 61,323,264 shares traded with an average volume of 61,204,460 (-4%):

Market Cap: 893,031,630

This firm offers artificial intelligence and machine learning for decision support, with a focus on cybersecurity, cloud engineering, and data analytics.

The flurry of public relations announcements about pending class action lawsuits and securities fraud allegations have triggered a downturn in the stock's recent price. (1, 2, 3)

- WeRide Inc. ($WRD NASDAQ) - 48,306,154 shares traded with an average volume of 3,589,956 (32%):

Market Cap: 773,113,193

Based in China, it develops autonomous driving technology offering smart services in logistics, transport, and sanitation through various robotic vehicles.

The expansion of the strategic partnership with Uber to introduce autonomous vehicles to 15 additional cities, coupled with the successful debut of the first fare-charging level-4 Robobus service in Guangzhou, spurred significant stock trading activity and drove up the share prices. (1, 2)

- Canaan Inc. ($CAN NASDAQ) - 39,834,512 shares traded with an average volume of 14,384,815 (-4%):

Market Cap: 172,101,543

Specializes in designing, selling and leasing integrated circuits and bitcoin mining equipment, alongside distributing artificial intelligence products globally.

- Opendoor Technologies Inc. ($OPEN NASDAQ) - 34,311,117 shares traded with an average volume of 48,508,341 (-5%):

Market Cap: 511,102,576

This digital platform-based firm offers online residential real estate services, including buying, selling, title insurance, and escrow, in the U.S.

The announcement of the first quarter financial results of 2025 and the emergence of a class action lawsuit against the firm substantially influenced recent fluctuations in stock price, with traded shares falling 5% short of the average volume. (1, 2)

🏦 Recent & Relevant IPOs

Gores Holdings X, Inc. surpassed other recent small-cap IPOs with a notable market cap of $312M on NASDAQ on May 2, 2025.

- Gores Holdings X, Inc. Units ($GTENU) on NASDAQ (2025-05-02). Market Cap: $312,000,000

- Winchester Bancorp, Inc. Common Stock ($WSBK) on NASDAQ (2025-05-02). Market Cap: $39,970,120

- Cartesian Growth Corporation III Unit ($CGCTU) on NASDAQ (2025-05-02). Market Cap: $240,000,000

- Cantor Equity Partners II, Inc. Class A Ordinary Share ($CEPT) on NASDAQ (2025-05-02). Market Cap: $240,000,000

- Smart Digital Group Limited Ordinary Shares ($SDM) on NASDAQ (2025-05-02). Market Cap: $6,000,000

Post Of The Day

💵 Recent Earnings

Looks like the energy sector is snapping back to life with Select Energy Services and Bristow Group beating earnings estimates, while First Watch Restaurant Group left foodies famished with a below-expectations performance.

Announced Yesterday:

-Select Energy Services, Inc. $WTTR ( ▼ 0.75% ) - Provides water management, chemical solutions, and infrastructure services to the onshore oil and gas industry in the U.S.

• Revenue: 374,384,000 vs est. 360,781,120 (4%), EPS: 0.1225 vs est. 0.07 (75%)

• Market Cap: 853,754,640

• Sector, Industry: Energy, Oil & Gas Equipment & Services

- Bristow Group Inc. $VTOL ( ▼ 1.72% ) - Provides aviation services and helicopter-based transportation to offshore energy companies globally from its base in Houston, Texas.

• Revenue: 350,530,000 vs est. 353,000,000 (-1%), EPS: 0.91 vs est. 0.58 (57%)

• Market Cap: 848,583,597

• Sector, Industry: Energy, Oil & Gas Equipment & Services

- Array Technologies, Inc. $ARRY ( ▼ 1.86% ) - A global manufacturer and supplier of solar tracking systems and machine learning software for energy production optimization.

• Revenue: 302,363,000 vs est. 282,054,670 (7%), EPS: 0.13 vs est. 0.09 (44%)

• Market Cap: 785,441,950

• Sector, Industry: Energy, Solar

- XPEL, Inc. $XPEL ( ▲ 0.03% ) - Manufactures and distributes automotive products such as protection films and merchandise, selling to independent installers and dealerships globally.

• Revenue: 103,805,000 vs est. 118,801,000 (-13%), EPS: 0.31 vs est. 0.25 (24%)

• Market Cap: 924,413,046

• Sector, Industry: Consumer Cyclical, Auto - Parts

- The Pennant Group, Inc. $PNTG ( ▼ 1.0% ) - Provides home health, hospice, and senior living services across the United States.

• Revenue: 209,842,000 vs est. 201,461,750 (4%), EPS: 0.27 vs est. 0.22 (23%)

• Market Cap: 931,946,532

• Sector, Industry: Healthcare, Medical - Care Facilities

- Helios Technologies, Inc. $HLIO ( ▼ 1.51% ) - Develops, manufactures, and sells hydraulic and electronic solutions globally, for industrial usage under various brand names.

• Revenue: 195,500,000 vs est. 204,360,750 (-4%), EPS: 0.44 vs est. 0.36 (22%)

• Market Cap: 904,291,734

• Sector, Industry: Industrials, Industrial - Machinery

- SolarEdge Technologies, Inc. $SEDG ( ▼ 2.71% ) - Designs and sells optimized inverter systems for solar photovoltaic installations and offers related energy management and grid services worldwide.

• Revenue: 219,480,000 vs est. 261,450,000 (-16%), EPS: -1.14 vs est. -1.2 (5%)

• Market Cap: 848,446,473

• Sector, Industry: Energy, Solar

- MFA Financial, Inc. $MFA ( ▲ 0.42% ) - A real estate investment trust in the U.S. focusing on residential mortgage assets and related assets.

• Revenue: 57,537,000 vs est. 45,100,000 (28%), EPS: 0.29 vs est. 0.39 (-26%)

• Market Cap: 962,885,140

• Sector, Industry: Real Estate, REIT - Mortgage

- First Watch Restaurant Group, Inc. $FWRG ( ▲ 3.33% ) - First Watch Restaurant Group, Inc. operates and franchises 435 First Watch-branded restaurants across 28 states in the United States.

• Revenue: 282,240,000 vs est. 307,144,400 (-8%), EPS: -0.03694 vs est. 0.04 (-192%)

• Market Cap: 934,649,772

• Sector, Industry: Consumer Cyclical, Restaurants

👀 Stocks To Add To Your Watchlist

$HCKT ( ▼ 0.26% ) · NASDAQ Global Select — The Hackett Group, Inc.

Technology/Information Technology Services · YTD: -96.755%

Despite experiencing a recent dip in its stock price, The Hackett Group, Inc. (HCKT) remains a compelling pick within the technology sector, particularly for investors interested in the burgeoning field of Generative Artificial Intelligence (Gen AI).

The company has demonstrated a strategic focus on expanding its Gen AI capabilities, evident from the launch of its AI XPLR™ 3.0 platform and the Gen AI-focused Executive Advisory Program. With a solid track record of innovation and a proactive approach to integrating Gen AI into its service offerings, HCKT is well-positioned to capitalize on the growing demand for AI-driven business transformation solutions.

$BLDP ( ▼ 5.0% ) · NASDAQ Global Market — Ballard Power Systems Inc.

Industrials/Industrial - Machinery · YTD: -41.52%

A prominent player in PEM fuel cell production, experienced minor setbacks with a first-quarter 2025 performance that fell slightly below expectations, coupled with a nearly 10% sequential order backlog drop. Despite these challenges, the company's strategic adjustments have effectively reduced operating expenses and curtailed cash burn, suggesting resilience.

With a fluctuating recent stock performance, highlighted by a closing price of $1.21 on May 6, 2025, following a -3.2% change, Ballard presents a cautious investment opportunity, especially considering its potential longevity sans additional capital infusion. Investors should closely observe Ballard's evolving market position and the broader industrials sector's performance for strategic entry points.

$ATRO ( ▼ 1.34% ) · NASDAQ Global Select — Astronics Corporation

Industrials/Aerospace & Defense · YTD: -93.839%

A key player in the aerospace and defense sector, reported an impressive 11% revenue growth in Q1 2025, driven by record aerospace sales. This performance is particularly noteworthy against a backdrop of market volatility and challenging US-China trade dynamics.

Astronics continues to innovate, as evidenced by their recent technology award for in-seat power solutions and a contract to supply NASA's Boeing X-66 Demonstrator Aircraft. With a consistent focus on advancing aerospace and defense technologies, ATRO offers investors a promising opportunity amid uncertain market conditions.

$SSSS ( ▼ 1.08% ) · NASDAQ Global Select — SuRo Capital Corp.

Financial Services/Asset Management · YTD: -83.278%

Recently showcased its investment acumen with its portfolio company, CoreWeave, completing the largest tech IPO since 2021 and another, OpenAI, closing the largest venture round with a staggering $300 billion valuation.

Despite broader market volatilities, SuRo Capital's net asset value per share stands resilient at $6.66 as of Q1 2025. The firm's strategic bets on high-growth ventures highlight its potential in the financial services sector, suggesting a potentially undervalued opportunity at its current price of $5.2.

$LFVN ( ▼ 0.79% ) · NASDAQ Capital Market — LifeVantage Corporation

Consumer Defensive/Packaged Foods · YTD: -94.253%

A pioneer in nutrigenomic health products, has shown a notable performance with a 21.1% revenue increase in Q3 2025. Despite recent market volatility, LFVN continues to expand its global reach while strategically enhancing shareholder value through a 12.5% dividend increase.

Given its innovative product line expansion and recent positive financial outcomes, LFVN represents an attractive opportunity for investors eyeing growth in the defensive consumer sector amidst market uncertainties.

That’s it for this episode!

Thank you for taking the time to read today’s email! Your support is what allows me to send out this newsletter for free every week. 

Disclaimer: This newsletter is for informational purposes only and contains forward-looking statements that involve risks and uncertainties. Investor Insights Systems does not provide financial advice—please consult a licensed advisor before making investment decisions.